2666 — Genertec Universal Medical Co Income Statement
0.000.00%
Last trade - 00:00
- HK$8.87bn
- HK$60.51bn
- CNY13.65bn
- 34
- 94
- 70
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,816 | 8,521 | 9,914 | 12,073 | 13,650 |
Cost of Revenue | |||||
Gross Profit | 3,179 | 3,554 | 4,199 | 4,494 | 4,572 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,595 | 6,137 | 7,207 | 9,348 | 10,751 |
Operating Profit | 2,220 | 2,384 | 2,707 | 2,725 | 2,899 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 2,212 | 2,365 | 2,692 | 2,703 | 2,866 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,634 | 1,814 | 2,030 | 2,086 | 2,199 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,588 | 1,747 | 1,948 | 1,960 | 2,110 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,489 | 1,648 | 1,835 | 1,926 | 2,062 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.965 | 1.07 | 1.02 | 0.929 | 0.99 |
Dividends per Share |